Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-12

FDA Approved: ALBUTEROL SULFATE INHALATION SOLUTION, 0.5% — Original Application (Ritedose Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved ALBUTEROL SULFATE INHALATION SOLUTION, 0.5% from Ritedose Pharmaceuticals under an Abbreviated New Drug Application (generic). It is indicated for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALBUTEROL SULFATE INHALATION SOLUTION, 0.5% (albuterol sulfate)

Snippet

ORIG AP for ALBUTEROL SULFATE INHALATION SOLUTION, 0.5% (ALBUTEROL SULFATE)